title: Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach.
abstract: Polycystic ovary syndrome (PCOS) constitutes a continuum spectrum of symptoms starting from the early prepubertal years and continuing after menopause. The phenotypic expression varies through time, depending on several internal (e.g. ovarian/adrenal steroidogenesis, insulin resistance) and external factors (e.g. quality and quantity of food, exercise). Moreover, the emergence of new definitions with the use of ovarian morphology, besides chronic anovulation and hyperandrogenism, as diagnostic criteria, increased the phenotypic variety of PCOS presentation. In this review, the clinician is provided with useful information regarding grey zones in assessing anovulation, hyperandrogenism, ovarian morphology and the difficulties in differential diagnosis of PCOS. Furthermore, the lack of substantial data characterizing metabolic/hormonal profile and the potential cardiovascular risk in newer PCOS phenotypes, as well as the absence of longitudinal data questioning a possible shift from one phenotype to another are underlined. These notions indicate that despite the initial presentation of a patient with PCOS, close follow-up and therapeutic interventions aiming to reduce long-term cardiovascular risk are warranted.
authors.affiliation: Endocrine Unit, Third Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Sarantis
authors.initials: S
authors.lastname: Livadas
authors.forename: Evanthia
authors.initials: E
authors.lastname: Diamanti-Kandarakis
mesh_terms: D000293:Adolescent; D000328:Adult; D000858:Anovulation / Q000175:diagnosis; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003937:Diagnosis, Differential; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood; D006628:Hirsutism / Q000175:diagnosis; D006801:Humans; D017588:Hyperandrogenism / Q000175:diagnosis; D007333:Insulin Resistance; D015596:Nutrition Assessment; D010641:Phenotype; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis*; D012307:Risk Factors
chemical_list: D017127:Glycation End Products, Advanced